Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT). Read more about Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT).
Revealing the Protein Propionylation Activity of the Histone Acetyltransferase Males absent on the first (MOF). Read more about Revealing the Protein Propionylation Activity of the Histone Acetyltransferase Males absent on the first (MOF).
Cloning, expression and purification of kinase domains of cacao PR-1 receptor-like kinases. Read more about Cloning, expression and purification of kinase domains of cacao PR-1 receptor-like kinases.
An AKAP-Lbc-RhoA interaction inhibitor promotes the translocation of aquaporin-2 to the plasma membrane of renal collecting duct principal cells. Read more about An AKAP-Lbc-RhoA interaction inhibitor promotes the translocation of aquaporin-2 to the plasma membrane of renal collecting duct principal cells.
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation. Read more about Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.
Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors. Read more about Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors.
CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary Function. Read more about CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary Function.
Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry. Read more about Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry.
Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63. Read more about Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63.
Creation of a novel class of potent and selective MutT Homolog 1 (MTH1) inhibitors using fragment-based screening and structure-based drug design. Read more about Creation of a novel class of potent and selective MutT Homolog 1 (MTH1) inhibitors using fragment-based screening and structure-based drug design.
